Pall Life Sciences at INTERPHEX ASIA

                              Technologies and Presentations

SUNTEC, Singapore (June 27, 2006) - - Pall Corporation is showcasing the products and technologies below at INTERPHEX Asia 2006, SUNTEC, Singapore, 27-29 June 2006, Booth # D22. Executives are available to discuss their applications:

View the complete press release at our website.

 

Pall Launches Flexible Containment System to Asian Market
for Safe Handling of Potent Pharmaceutical Compounds

SUNTEC, Singapore (27 June 2006) - - Protecting workers and the surrounding environment from exposure to hazardous compounds poses an increasing challenge to pharmaceutical manufacturers as new and more potent Active Pharmaceutical Ingredients (APIs) enter the processing pipeline, such as cytotoxic (cell killing) drugs to treat cancer. Separation and purification processes potentially expose workers to harmful, biologically active, contaminating particulates and catalysts filtered from the APIs.  To help remedy the problem, Pall Corporation (NYSE: PLL) is introducing to Asia the GBK Containment System which provides the pharmaceutical industry with its first all-in-one contained glove bag/housing system for filter change-out. 

 

The flexible, user-friendly system reduces the risk of cross contamination and shields operators from exposure to harmful compounds when handling APIs during filter change-out procedures. Operators can easily access replacement filters from zippered feed-in sleeves and then remove spent filter cartridges through a feed-out sleeve using nitrile gloves.  The user-friendly system enables trained operators to perform a complete filter cartridge change-out in less than two minutes on average.

  

Currently about 5 to 10 percent of commercially available drugs are high potency.  With more potent and targeted drug molecules under development, this figure increases to about 25 percent and is the fastest growing segment of small-molecule custom synthesis.  The increased need for new and enhanced containment solutions is also driven by the growing investment of both major pharmaceutical companies and small biotech firms in the anticancer area.

 

“This global trend is a serious concern for drug manufacturers which need to set new occupational exposure limits (OELs) into their operations,” says reports Holly Haughney, Ph.D., vice president, Pall BioPharmaceuticals Marketing Asia. “The introduction of our GBK containment system provides an innovative, compact and cost-efficient solution to help meet this critical industry need.”

 

The GBK System provides a convenient alternative to glove boxes and other bulky isolation systems that can require more costly capital expense and more manufacturing floor space. GBK glove bags are made of antistatic polyurethane with a built-in HEPA filter to prevent condensation.  They are available with double zippered feed-in sleeves for maximum operational flexibility and feature an elastic ring that ensures an effective seal to the housing to prevent airborne particles from escaping.  GBK gloves bags are also available with sealed sleeves for more critical applications where additional protection is needed.

 

The GBK system can be used for multiple steps in a production process. After a batch or campaign is completed, plastic bags and gloves can be easily discarded.  For multi-purpose manufacturing sites, the GBK system also protects from cross-contamination between different systems that might otherwise be susceptible to airborne contamination.  Independent tests with a worst-case containment challenge show that the GBK system could be used to provide a containment level to 1 µg/m3.  The Pall PATK series housings incorporated in the GBK containment system offer a robust design for secure locking code seven cartridges, ideal for API applications.  For each installation, Pall specialists will provide technical support and user training.

 

The GBK system is the latest addition to Pall’s extensive line of filtration and processing innovations. As a total solutions provider to the pharmaceutical marketplace aligned to customer needs, Pall’s technologies help improve drug-processing safety, efficiency and speed time-to-market of new therapies.

About Pall Corporation

Pall Corporation is the global leader in the rapidly growing field of filtration, separations and purification.  Pall's business is organized around two broad markets: Life Sciences and Industrial.  The Company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, semiconductor, water purification, aerospace and broad industrial markets.  Total revenues for fiscal 2005 were $1.9 billion.  The Company headquarters is in East Hills, New York with extensive operations throughout the world. Visit Pall at http://www.pall.com.

 

 

# # #

Editor’s Note: 

• Photos are available on http://www.pall.com/corporate_39417.asp.
• The GBK Containment System will be on display at INTERPHEX ASIA 2006, 27-29 June, SUNTEC Singapore, booth #D22.

 

View the complete press release at our website.